Special items: Ovarian Cancer and Us blog best viewed in Firefox

Sunday, January 17, 2010

abstract: Pharmacogenomics of taxane/platinum therapy in ovarian cancer

epigentics: The study of heritable changes in gene function that occur without a change in the DNA sequence

"CONCLUSIONS: Other mechanisms of variability, including epigenetic control of gene expression and copy number variation, may play important roles. In addition, nongenetic influences such as concurrent medications, and physiological and environmental factors could also affect individual responses to taxane and platinum therapy."

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.